Market closed
MBX Biosciences, Inc./$MBX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MBX Biosciences, Inc.
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
Ticker
$MBX
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
43
Website
MBX Metrics
BasicAdvanced
$213M
-
-$5.82
-
-
Price and volume
Market cap
$213M
52-week high
$11.47
52-week low
$6.33
Financial strength
Current ratio
24.187
Quick ratio
23.783
Total debt to equity
0.066
Management effectiveness
Return on assets (TTM)
-24.17%
Return on equity (TTM)
-36.71%
Valuation
Price to book
0.83
Price to tangible book (TTM)
0.83
Price to free cash flow (TTM)
-1.22
Growth
Earnings per share change (TTM)
-81.80%
MBX News
AllArticlesVideos
MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewsWire·1 week ago
MBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
GlobeNewsWire·3 weeks ago
MBX Biosciences Announces Additions to Leadership Team
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for MBX Biosciences, Inc. stock?
MBX Biosciences, Inc. (MBX) has a market cap of $213M as of April 05, 2025.
What is the P/E ratio for MBX Biosciences, Inc. stock?
The price to earnings (P/E) ratio for MBX Biosciences, Inc. (MBX) stock is 0 as of April 05, 2025.
Does MBX Biosciences, Inc. stock pay dividends?
No, MBX Biosciences, Inc. (MBX) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next MBX Biosciences, Inc. dividend payment date?
MBX Biosciences, Inc. (MBX) stock does not pay dividends to its shareholders.
What is the beta indicator for MBX Biosciences, Inc.?
MBX Biosciences, Inc. (MBX) does not currently have a Beta indicator.